People with myotonic dystrophy type 1 (DM1), the most common adult-onset form of muscular dystrophy, progressively lose ...
1). Like many other muscular dystrophies ... ARTHEx also has ATX-01 in preclinical testing for myotonic dystrophy type 2 (DM2). “Although DM2 is caused by a different mutation, it similarly ...
On their family farm in rural Illinois, the Flessner boys have free range. But early on, something was holding older brother ...
Delpacibart zotadirsen is under clinical development by Avidity Biosciences and currently in Phase II for Duchenne Muscular Dystrophy.
Muscular Dystrophy News Today covered the latest studies, treatment advances, and clinical trials for different types of the ...
Exciting news in the biotech industry as positive phase 2 results for sevasemten in BMD drive long-term investment potential ...
A groundbreaking study has shed light on the complex interactions between dystrophin, a protein critical to muscle stability, and its partner protein, dystrobrevin, offering new pathways for ...
PHOENIX (AZFamily) —As we head toward the new year, the medical advances just keep coming for the muscular dystrophy community. New treatments and therapies are being approved to help families ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback